Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04231552
What this trial is testing

Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06872606
What this trial is testing

Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer

Who this might be right for
Rectal Adenocarcinoma
Sir Run Run Shaw Hospital 33
Not applicableStudy completedNCT03287843
What this trial is testing

Appropriate Timing of Surgery After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Who this might be right for
Neoplasm, Rectum
Ege University 350
Large-scale testing (Phase 3)Active Not RecruitingNCT06507371
What this trial is testing

Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer

Who this might be right for
Rectal Cancer
Sir Run Run Shaw Hospital 170
Not applicableUnknownNCT04717947
What this trial is testing

Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)

Who this might be right for
Rectal CancerNeoadjuvant Therapy
Hospital Clinic of Barcelona 911
Early research (Phase 1)Study completedNCT01589419
What this trial is testing

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
AbbVie (prior sponsor, Abbott) 32
Large-scale testing (Phase 3)Study completedNCT01186081
What this trial is testing

Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Asan Medical Center 240
Testing effectiveness (Phase 2)Looking for participantsNCT07026422
What this trial is testing

Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)

Who this might be right for
Rectal Malignant Neoplasms
Shandong Cancer Hospital and Institute 54
Testing effectiveness (Phase 2)Looking for participantsNCT07239466
What this trial is testing

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy+1 more
Tao Zhang 25
Testing effectiveness (Phase 2)Ended earlyNCT00006001
What this trial is testing

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Active Not RecruitingNCT06246344
What this trial is testing

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Shandong Cancer Hospital and Institute 128
Not applicableUnknownNCT02036112
What this trial is testing

Conventional Versus Individual Extralvator Abdominoperineal Excision for Advanced Lower Rectal Cancer

Who this might be right for
Rectal Cancer
Beijing Chao Yang Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02569645
What this trial is testing

Rosuvastatin in the Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
AHS Cancer Control Alberta 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07248020
What this trial is testing

A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue

Who this might be right for
Rectal CancerLocally Advanced Rectal CancerRadiation-Induced Enteritis+2 more
Chang Gung Memorial Hospital 72
Testing effectiveness (Phase 2)Study completedNCT04009876
What this trial is testing

Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Fundación de investigación HM 30
Not applicableActive Not RecruitingNCT04223102
What this trial is testing

Microbiome and Rectal Cancer

Who this might be right for
Rectal CancerLocally Advanced Malignant Neoplasm
University of South Florida 40
Large-scale testing (Phase 3)Looking for participantsNCT05646511
What this trial is testing

TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
National Cancer Center Hospital East 608
Testing effectiveness (Phase 2)Study completedNCT00807911
What this trial is testing

Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

Who this might be right for
Rectal Cancer
Asan Medical Center 322
Not applicableUnknownNCT01951521
What this trial is testing

RECTAL BOOST Study

Who this might be right for
Rectal Cancer
UMC Utrecht 128
Testing effectiveness (Phase 2)UnknownNCT04621370
What this trial is testing

A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Neoplasms
Liz-Anne Lewsley 48
Next Page